The blood grouping reagents market in Italy exhibited fluctuating trends from 2013 to 2016, with a notable decline followed by a significant upturn starting in 2017. From 2021 onwards, the market saw steady annual growth, culminating at $95.043 million in 2023. The most recent two-year year-on-year variations recorded were 1.55% in 2022 and 1.51% in 2023. The last five-year CAGR through 2023 stood at 1.53%, indicating moderate but consistent growth. Looking ahead, forecasts suggest continued growth with a projected CAGR of 1.11% over the next five years, reaching $101.9 million by 2028.
Future trends to watch for in the blood grouping reagents market include:
- Technological advancements in reagent development
- Increasing demand for blood transfusions and related diagnostics due to an aging population
- Expansion in healthcare infrastructure and blood donation awareness campaigns
- Regulatory changes and their impacts on market dynamics
